Search for Abstracts Find by Title, Author or Description Year Abstracts - 2022 - 2021 - 2020 - 2019 - 2018 - 2017 - 2016 - 2015 - 2014 - 2013 - 2012 - 2011 - 2010 - 2009 Tags AB Applied Basic Science Basic Science BT Clinical Clinical-Chemotherapy-SSA-Biologics Clinical-PRRT-Nuclear Clinical-Surgical-Applied_Pathology OT Other P Population Science Poster T Trials In Progress Search Reset Order by Title Alphabetical Title Reverse Alphabetical Most Recent First Oldest First Most popular first Last modified first B1 - Metastatic Pancreatic Neuroendocrine Tumors Have Decreased Somatostatin Expression and Increased Akt Signaling Published in 2020 Listed under Basic Science Download C. Tran, A. Scott, G. Li, S. Sherman, P.H. Ear, J. Howe ABSTRACT ID: 104 B10 - The Importance of Dedicated Nurse Navigation for PRRT Therapy Published in 2020 Listed under Applied Basic Science Download R. Mirro ABSTRACT ID: 29 B11 - Clinicopathological and Genomic Features in Patients With Head and Neck Neuroendocrine Carcinoma Published in 2020 Listed under Applied Basic Science Download A. Ohmoto, Y. Sato, Y. Fujiwara, N. Fukuda, X. Wang, T. Urasaki, N. Hayashi, Y. Sato, K.Nakano, M. Yunokawa, M. Ono, J. Tomomatsu, S. Takahashi ABSTRACT ID: 101 B12 - Functional Genetic Screen to Identify Drivers of Pancreatic Neuroendocrine Tumor Pathogenesis Published in 2020 Listed under Applied Basic Science Download C.K. Maharjan, J. Riordan, C. Fedderson, E. Zhu, B. Darbro, A. Dupuy, D. Quelle ABSTRACT ID: 132 B13 - Efficacy of Combined MEK and CDK Targeted Therapies for Pancreatic Neuroendocrine Tumors Published in 2020 Listed under Applied Basic Science Download U.S. Shaik Amjad, C. Kaemmer, M. Chandra, J. Kohlmeyer, G. D, W. S, R. Sheehy, L. Mr ,D. Meyerholz, G. Zamba, S. O'Dorisio, J. Dillon, A. Scott, E.P. Hein, J. Howe, C. Chandrasekharan, A. Bellizzi, L. Herring, L. Graves, B. Darbro, D. Quelle ABSTRACT ID: 146 B14 - A Blood-Based Neuroendocrine Tumor Mrna Signature Identifies Residual Tumor and Accurately Predicts Recurrence After Surgery Published in 2020 Listed under Applied Basic Science Download I. Modlin, M. Falconi, P.L. Filosso, A. Frilling, A. Malczewska, M. Kidd, K. Oberg ABSTRACT ID: 148 B15 - Mapping Anti-Angiogenic Proteome Associated With Black Raspberry Extract and Gallic Acid in Neuroendocrine Cancer Published in 2020 Listed under Applied Basic Science Download J. Mehrez, B. Gentile, N. Skill, T. Milosavljevic, E. Chouest, M. Maluccio, E. Woltering ABSTRACT ID: 179 B16 - A Systematic Workflow to Identify Anti-cancer Drugs Targeting Small BowelNeuroendocrine Tumors and Neuroendocrine Carcinomas Published in 2020 Listed under Applied Basic Science Download P. H. Ear, C. Tran, G. Li, J. Egan, C. Lotenschtein, E. Abusada, J. Mudd, C. Kaemmer, A. Miller, C. Chan, C. Chandrasekharan, M. Wu, S. O'Dorisio, D. Quelle, A. Bellizzi, R. C. Fields, J. Howe ABSTRACT ID: 196 B17 - Preclinical Evaluation of Radionuclide Therapy Targeting CXCR4 and Thioredoxin Reductase in Atypical Carcinoid and Neuroendocrine Carcinoma Published in 2020 Listed under Applied Basic Science Download D. Liu, M. Fath, C. Robles Planells, J. Ewald, D. Spitz, M. O'Dorisio ABSTRACT ID: 198 B2 - Proteotranscriptomic Classification and Characterization of Pancreatic Neuroendocrine Neoplasms Published in 2020 Listed under Basic Science Download K. Yang, S. Kalloger, J. Aird, M. Lee, C. Rushton, S. Spencer Miko ,K. Mungall, A. Mungall, S. Colborne, R. Morin, J. Loree, M. Marra, D. Renouf, G. Morin, D. Schaeffer, S. Gorski ABSTRACT ID: 105 B3 - Telotristat Ethyl Augments Cytotoxic Chemotherapy Response in Preclinical Tumor Models Published in 2020 Listed under Basic Science Download N. Awasthi, M. Schwarz, R. Schwarz ABSTRACT ID: 120 B4 - Neuroendocrine Tumor Omic Gene Cluster Analysis Amplifies the Prognostic Accuracy of the NETest Published in 2020 Listed under Basic Science Download M. Kidd, A. Kitz, I. Drozdov, I. Modlin ABSTRACT ID: 158 B5 - Exploring Plasma-Derived Exosomes (PDEs) as a Response Biomarker in Neuroendocrine Tumors (NETs) Published in 2020 Listed under Basic Science Download M. Gupta, O. Maguire, M. Bapardekar, K. Attwood, H. Minderman,R. Iyer ABSTRACT ID: 177 B6 - The Anti-Proliferative Effects of the Mycotoxin Verrucarin A on Neuroendocrine Tumor Cells Published in 2020 Listed under Basic Science Download J. Whitt, Z. Patel, R. Guenter, H. Chen, R. Jaskula-Sztul ABSTRACT ID: 182 B7 - MAML3 Overexpression Increases Tumorgenicity in Several Neuroendocrine Tumor Types Published in 2020 Download N. Alzofon, K. Koc, K. Panwell, N. Pozdeyev, C. Marshall, M. Albuja-Cruz, C. Raeburn, K. Nathanson, D. Cohen, M. Wierman, K. Kiseljak-Vassiliades, L. Fishbein ABSTRACT ID: 187 B8 - The Lineage Transcription Factors ASCL1, NKX2-1, and PROX1 Form a Regulatory Network and Control the Expression of the Ion Channel, SCN3A, in Small Cell Lung Cancer Published in 2020 Download K. Pozo, R. Kollipara, D. Kelenis, K. Rodarte, X. Zhang, J. Minna, J.Johnson ABSTRACT ID: 195 B9 - 5-Azacitidine Inhibits Neuroendocrine Tumors via the Induction of Notch3 by theTransactivator BORIS Published in 2020 Download R. Zheng-Pywell , J. Whitt, K. Hale, H. Chen, R. Jaskula-Sztul, J.B. Rose ABSTRACT ID: 203 C1 - Preliminary Safety, PK/PD, and Antitumor Activity of XmAb18087, an SSTR2 x CD3 Bispecific Antibody, in Patients with Advanced Neuroendocrine Tumors Published in 2020 Listed under Clinical-Chemotherapy-SSA-Biologics Download B. El-Rayes, S. Pant, V. Villalobos, A. Hendifar, W. Chow, B. Konda, M. Reilley, A. Benson, G. Fisher, J. Starr, J. Strosberg, D. Ahn, K. Perez, N. Raj, J. Eads, T. Hobday, S. Chollate, Y. Ding, C. Fleener, J. Shorr ABSTRACT ID: 111 C10 - Treatment Outcomes of Well- Differentiated High-Grade Neuroendocrine Tumors Published in 2020 Listed under Clinical-Chemotherapy-SSA-Biologics Download A. Liu, B. Ueberroth, P. McGarrah, S. Buckner Petty, A. Kendi, J. Starr, T. Hobday, T. Halfdanarson, M. Sonbol ABSTRACT ID: 143 C11 - Comparative Analysis of Octreotide Long Acting Release (LAR) and Lanreotide in Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): A Single Institution Experience Published in 2020 Listed under Clinical-Chemotherapy-SSA-Biologics Download S. Wu, P. Reta-Impey, N. Manivannan, S.H. Tirumani, P. Fu, S. Cao, S. Asa, A. Kardan, F. Liu, N. Avril, P. Wojtylak, R. Lee, D. Bajor, E. Selfridge, J. Saltzman, J. Hardacre, J. Ammori, J. Winter, A. Mohamed C12 - A Single-Centre Pilot Study for Radiosensitization of Everolimus with External Beam Radiotherapy for the Treatment of Metastatic Neuroendocrine Liver Metastasis Published in 2020 Listed under Clinical-Chemotherapy-SSA-Biologics Download S. Myrehaug, D. Chan, V. Rodriguez Freixinos, C. Law, J. Hallet, J. Hudson, S. Singh ABSTRACT ID: 152 C13 - Efficacy of FOLFOX With Or Without Bevacizumab in Patients With Aggressive Pancreatic NETs After Prior Capecitabine/Temozolomide Published in 2020 Listed under Clinical-Chemotherapy-SSA-Biologics Download T. Al-Toubah, B. Morse, E. Pelle, J. Strosberg ABSTRACT ID: 156 C14 - Efficacy and Toxicity Analysis of Capecitabine and Temozolomide in Neuroendocrine Neoplasms Published in 2020 Listed under Clinical-Chemotherapy-SSA-Biologics Download T. Al-Toubah, E. Pelle, T. Valone, M. Haider, J. Strosberg ABSTRACT ID: 157 C15 - Concurrent Everolimus with Hepatic Transarterial Bland Embolotherapy (Evero-Embo) in Patients with Metastatic Well Differentiated Neuroendocrine Tumor (NET) Published in 2020 Listed under Clinical-Chemotherapy-SSA-Biologics Download L. Anthony, G. Gabriel, A. Chauhan, R. El Khouli ABSTRACT ID: 159 C16 - Comparative Outcomes of Second Line Topoisomerase I Inhibitor- Containing Therapies on Extrapulmonary Neuroendocrine Carcinoma Published in 2020 Listed under Clinical-Chemotherapy-SSA-Biologics Download H.-M. Yeung, K. Sreekrishnanilayam, C. Meeker, M. Deng, S. Agrawal, H. Abdullah, E. Ross, N. Vijayvergia ABSTRACT ID: 162 C17 - The Clinical Impact of Serum Chromogranin-A in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETS) Published in 2020 Listed under Clinical-Chemotherapy-SSA-Biologics Download S. Wu, P. Reta-Impey, N. Manivannan, P. Fu, S. Cao, S. Asa, S.H. Tirumani, J. Davidson, A. Kardan, N. Avril, P. Wojtylak, D. Bajor, R. Lee, E. Selfridge, J. Saltzman, J. Ammori, J. Hardacre, J. Winter, A. Mohamed ABSTRACT ID: 163 C18 - Avelumab in Unresectable/ Metastatic, Progressive, Grade 2-3 Neuroendocrine Neoplasms (NEN): Combined Results from NET-001 and NET-002 Trials Published in 2020 Listed under Clinical-Chemotherapy-SSA-Biologics Download D. Chan, V. Rodriguez Freixinos, M. Doherty, K. Wasson, N. Iscoe, W. Raskin, J. Hallet, S. Myrehaug, C. Law, A. Thawer, K. Nguyen, S. Singh ABSTRACT ID: 164 C19 - Urinary Neuroendocrine Neoplasms Treated in the “Modern Era”: A Multicenter Retrospective Review Published in 2020 Listed under Clinical-Chemotherapy-SSA-Biologics Download B. Le, P. McGarrah, J. Whitman, A. Paciorek, N. Raj, D. Reidy-Lagunes, H. Hauser, T. Le, J. Del Rivero, A. Apolo, E. Bergsland, T. Halfdanarson ABSTRACT ID: 185 C2 - Real-World Observational Study of Somatostatin Analogs and Rescue Medication Use for Neuroendocrine Tumors in Canada Published in 2020 Listed under Clinical-Chemotherapy-SSA-Biologics Download D. Rayson, V. Petrovic, C. Laforty, M. Badin, H. McKechnie ABSTRACT ID: 112 C20 - Efficacy of Somatostatin Analog (SSA) Monotherapy for Well-Differentiated Grade 3 (G3) Gastroenteropancreatic Neuroendocrine Tumors (NETs) Published in 2020 Listed under Clinical-Chemotherapy-SSA-Biologics Download P. McGarrah, A. Liu, T. Hobday, J. Starr, A. Kendi, R. Graham, T. Halfdanarson, M. Sonbol ABSTRACT ID: 200 C21 - Efficacy and Safety of Peptide Receptor Radionuclide Therapy in Lung Neuroendocrine Tumors: A Multicentre Study Published in 2020 Listed under Clinical-PRRT-Nuclear Download A. Iravani, L. Zidan, K. Oleinikov, S. Ben-Haim, D. Gross, A. Meirovitz, O. Maimon, T. Akhurst, M. Michael, R. Hicks, S. Grozinsky-Glasberg, G. Kong ABSTRACT ID: 15 C22 - Patient Travel Concerns After Treatment with Peptide Receptor Radionuclide Therapy (PRRT) Published in 2020 Listed under Clinical-PRRT-Nuclear Download A. Kendi, T. Halfdanarson, B. Naraev, D. Mercer, J. Underwood, J. Mailman ABSTRACT ID: 36 C23 - 177Lu-DOTATATE/DOTATOC Re-Treatment in Patients with Progressive Neuroendocrine Tumours: A Systematic Review and Meta-Analysis Published in 2020 Listed under Clinical-PRRT-Nuclear Download J. Strosberg, O. Leeuwenkamp, M.K. Siddiqui ABSTRACT ID: 43 C24 - A Clinical Score(CS) for Well- Differentiated Neuroendocrine Tumor(WD-NET) Patients(Pts) Undergoing Peptide Receptor Radionuclide Therapy(PRRT) Published in 2020 Listed under Clinical-PRRT-Nuclear Download S. Das, L. Du, A. Schad, S. Jain, A. Jessop, C. Shah, D. Eisner, D. Cardin, K. Ciombor, L. Goff, M. Bradshaw, D. Delbeke, M. Sandler, J. Berlin ABSTRACT ID: 44 C25 - The Use of Peptide Receptor Radionucleotide Therapy (PRRT) in Patients with Neuroendocrine Tumor Cardiac Metastases Published in 2020 Listed under Clinical-PRRT-Nuclear Download I. Yu, G. Funk, E. Lin, H. Kennecke ABSTRACT ID: 58 C26 - Safety of 177Lu DOTATATE in Patients with Advanced Neuroendocrine Tumors: Data from a US Expanded Access Program Published in 2020 Listed under Clinical-PRRT-Nuclear Download M. Allen-Auerbach, E. Wolin, V. Nassiri, P. Broberg, G. El-Haddad ABSTRACT ID: 118 C27 - Re-Treatment with 177Lu-DOTATATE in Patients With Neuroendocrine Tumors: Multicenter Real-World Experience Published in 2020 Listed under Clinical-PRRT-Nuclear Download S. Navalkissoor, M. Essler, M. Caplin, W. Van Der Zwan, M. Wicharz, W. De Herder, P. Broberg, E. Krenning ABSTRACT ID: 119 C28 - Supportive Management during PRRT for Symptomatic Pheochromocytomas or Paragangliomas Published in 2020 Listed under Clinical-PRRT-Nuclear Download E. Tsang, G. Funk, J. Leung, G. Kalish, H. Kennecke ABSTRACT ID: 134 C29 - Gallium-68 Dotatate PET/CT (Ga68PET/CT) Versus Contrast Enhanced Cross Sectional Imaging (CECSI) to Measure Treatment Response (TR) to Peptide Receptor Radionuclide Therapy (PRRT) in Patients With Neuroendocrine Tumors (NETs) Published in 2020 Listed under Clinical-PRRT-Nuclear Download D. Jackson, M. Downey, G. Kalish, E. Mittra, H. Kennecke ABSTRACT ID: 145 C3 - Patient-Reported Activity Impairment, Work Productivity Loss, and Carcinoid Syndrome Outcomes: Interim Analyses of the XERMELO Patient Registry Published in 2020 Listed under Clinical-Chemotherapy-SSA-Biologics Download C. Darden, V. Joish, M. Price, D. Garbinsky, S. Schwartz, C. Warner, S. Wason, P. Lapuerta ABSTRACT ID: 113 C30 - 64Cu-DOTATATE PET in Neuroendocrine Tumor Patients: What We Learned From the First 1,200 Patients Published in 2020 Listed under Clinical-PRRT-Nuclear Download A. Kjaer, E. Carlsen, M. Loft, C. Johnbeck, T. Binderup, S. Langer, B. Federspiel, U. Knigge ABSTRACT ID: 147 C31 - PRRT Neuroendocrine Tumor Response Monitored Using Circulating Transcript Analysis: The NETest Published in 2020 Listed under Clinical-PRRT-Nuclear Download L. Bodei, M. Kidd, A. Singh, W. Van Der Zwan, S. Severi, I. Drozdov, A. Malczewska, G. Paganelli, E. Krenning, I. Modlin ABSTRACT ID: 160 C32 - Dynamic Contrast-Enhanced CT to Evaluate Response in Neuroendocrine Liver Metastases Treated with Everolimus and Radiation Published in 2020 Listed under Clinical-PRRT-Nuclear Download J. Hudson, S. Singh, V. Rodriguez-Freixinos, D. Chan, J. Hallet, C. Law, S. Myrehaug ABSTRACT ID: 165 C33 - Association Between Surveillance Imaging and Survival Outcomes in Small Bowel Neuroendocrine Tumors Published in 2020 Listed under Clinical-PRRT-Nuclear Download A. Watanabe, L. Yip, G. McKendry, J. Loree, H. Stuart ABSTRACT ID: 167 C34 - An Initial Experience in Establishing a Theranostic Precision Medicine PRRT Targeted Radiotherapy Program for the Treatment of GEP-NETs with Lu-177 Dotatate (Lutathera) in a Major Academic University Hospital Published in 2020 Listed under Clinical-PRRT-Nuclear Download P. Wojtylak, A. Mohamed, N. Avril, A. Kardan ABSTRACT ID: 173 C35 - Real-World Analysis of Safety and Tolerance of Repeat Peptide Receptor Radionuclide Therapy Published in 2020 Listed under Clinical-PRRT-Nuclear Download J. Chau, H. Bakeri, N. Yu, Y. Menda, J. Dillon, C. Chandrasekharan ABSTRACT ID: 192 C36 - 212Pb-AlphaMedixTM Targeted Alpha Therapy (TAT): A Potential Breakthrough in Treatment of Metastatic SSTR Expressing NET Published in 2020 Listed under Clinical-PRRT-Nuclear Download E. Delpassand, I. Tworowska, J. Torgue, J. Hurt, R. Nuñez, R. Esfandiari ABSTRACT ID: 193 C37 - Single Institution Experience With Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors (NET) Published in 2020 Download H. Duan, V. Ferri, P. Kunz, G. Davidzon, J. Nguyen, F. Moradi, B. Franc, A. Iagaru, C. Aparici Mari ABSTRACT ID: 194 C38 - Hepatotoxicity in Previously Treated Y-90 Metastatic Neuroendocrine Cancer Patients after PRRT: Single Institution Experience Published in 2020 Listed under Clinical-PRRT-Nuclear Download Y.L. Wong, J. Thomas, A. Shreenivas ABSTRACT ID: 197 C39 - Hematotoxicity of Peptide Receptor Radionuclide Therapy (PRRT) – A Single Institution Experience Published in 2020 Listed under Clinical-PRRT-Nuclear Download H. Duan, V. Ferri, P. Kunz, G. Davidzon, F. Moradi, J. Nguyen, B. Franc, A. Iagaru, C. Aparici Mari ABSTRACT ID: 199 C4 - Carcinoid Syndrome (CS) Improvements in Patients Receiving Telotristat Ethyl (TE): Findings from TELEPRO-II Published in 2020 Listed under Clinical-Chemotherapy-SSA-Biologics Download M. Kulke, V. Di Gialleonardo, V. Joish, K. Murali, H. Kennecke ABSTRACT ID: 115 C40 - Renal and Hepatotoxicity of Peptide Receptor Radionuclide Therapy (PRRT) – A Single Institution Experience Published in 2020 Listed under Clinical-PRRT-Nuclear Download H. Duan, V. Ferri, P. Kunz, G. Davidzon, J. Nguyen, F. Moradi, B. Franc, A. Iagaru, C. Aparici Mari ABSTRACT ID: 201 C41 - Preoperative Risk Stratification of Lymph Node Metastasis for Non-Functional Pancreatic Neuroendocrine Neoplasm: An International Dual-Institutional Study Published in 2020 Listed under Clinical-Surgical-Applied_Pathology Download Y. Kasai, T. Masui, E. Nakakura, K. Nakano, A. Sato, Y. Uchida, A. Yogo, K. Nagai, T. Anazawa, T. Hope, G. Kim, J. Whitman, B. Le, K. Takaori, E. Bergsland, S. Uemoto ABSTRACT ID: 12 C42 - Response Rates in Metastatic Neuroendocrine Tumors Receiving Peptide Receptor Radionuclide Therapy and Implications for Future Treatment Strategies Published in 2020 Download T. Vaghaiwalla, B. Ruhle, K. Memeh, P. Angelos, E. Kaplan, B. Polite, C.-Y. Liao, X. Keutgen ABSTRACT ID: 13 C43 - Ultrasound-Guided Percutaneous Ethanol Ablation for Loco-Regional Recurrence of Medullary Thyroid Cancer Published in 2020 Listed under Clinical-Surgical-Applied_Pathology Download T. Szabo Yamashita, R. Rogers, M. Lyden, G. Thompson, T. Foster, J. Morris, T. McKenzie, B. Dy ABSTRACT ID: 46 C44 - ISL-1 Expression is a Prognostic Marker in Patients With Well- Differentiated Pancreatic Neuroendocrine Tumors Published in 2020 Listed under Clinical-Surgical-Applied_Pathology Download H. Assi, H. Hatoum, M. Maldonado-Vital, K.-M. Fung ABSTRACT ID: 62 C45 - It’s Time to Rethink Biomarkers for Surveillance of Small Bowel Neuroendocrine Tumors Published in 2020 Listed under Clinical-Surgical-Applied_Pathology Download C. Tran, S. Sherman, A. Scott, P.H. Ear, C. Chandrasekharan, A. Bellizzi, J. Dillon, T. O’Dorisio, J. Howe ABSTRACT ID: 103 C46 - Symptom and Quality Of Life Impairments in Cushing’s Disease Before and After Endoscopic Transsphenoidal Surgery Published in 2020 Listed under Clinical-Surgical-Applied_Pathology Download T. Huang, A. Baba, M. Cusimano ABSTRACT ID: 107 C47 - Predicting Metastatic Potential in Pheochromocytoma and Paraganglioma: A Comparison of PASS and GAPP Scoring Systems Published in 2020 Listed under Clinical-Surgical-Applied_Pathology Download H. Wachtel, T. Hutchens, E. Baraban, L. Schwartz, K. Montone, Z. Baloch, V. Livolsi, L. Krumeich, D. Fraker, K. Nathanson, D. Cohen, L. Fishbein ABSTRACT ID: 127 C48 - Metabolic Changes in Pheochromocytoma and Paraganglioma: Correlation Between Plasma Hormone Levels, Weight and Diabetes Published in 2020 Listed under Clinical-Surgical-Applied_Pathology Download L. Krumeich, A. Cucchiara, K. Nathanson, R. Kelz, L. Fishbein, D. Fraker, R. Roses, D. Cohen, H. Wachtel ABSTRACT ID: 128 C49 - Pattern of Disease Recurrence and Treatment after Surgery for Nonfunctioning Well- Differentiated Pancreatic Neuroendocrine Tumors (NF-PanNET) Published in 2020 Listed under Clinical-Surgical-Applied_Pathology Download V. Andreasi, S. Partelli, L. Landoni, C. Nessi, F. Muffatti, S. Crippa, S. Cingarlini, C. Bassi, M. Falconi ABSTRACT ID: 150 C5 - Efficacy of Telotristat Ethyl (TE) in Patients with Progressive Neuroendocrine Tumor Disease: Real World Clinical Practice Experience Published in 2020 Listed under Clinical-Chemotherapy-SSA-Biologics Download E. Liu, D. Metz, V. Joish, V. Di Gialleonardo, K. Murali, M. Morse ABSTRACT ID: 117 C50 - Socioeconomic Disparities in Midgut Neuroendocrine Tumors (MNETs): An NCDB Analysis Published in 2020 Listed under Clinical-Surgical-Applied_Pathology Download T. Diperi, N. Manguso, B. Cox, K. Atkins, A. Hendifar, J. Gong, A. Gangi ABSTRACT ID: 169 C51 - A Novel Stratification of Mesenteric Mass Involvement as a Predictor of Challenging Mesenteric Lymph Node Dissection by Minimally Invasive Approach for Ileal Neuroendocrine Tumors Published in 2020 Listed under Clinical-Surgical-Applied_Pathology Download Y. Kasai, K. Mahuron, K. Hirose, C. Corvera, G. Kim, T. Hope, R. Warren, E. Bergsland, E. Nakakura ABSTRACT ID: 172 C52 - Upfront Interventional Treatments Prior to Liver-progression for Small Bowel Neuroendocrine Liver Metastasis Published in 2020 Listed under Clinical-Surgical-Applied_Pathology Download Y. Kasai, K. Hirose, C. Corvera, G. Kim, T. Hope, N. Fidelman, R. Warren, E. Bergsland, E. Nakakura ABSTRACT ID: 174 C53 - Well-Differentiated Rectal Neuroendocrine Tumors: Analysis of Histology, Including INSM1 Expression, and Biologic Behavior, Involving a Large Cohort of 94 Cases Published in 2020 Listed under Clinical-Surgical-Applied_Pathology Download R. Sappenfield ABSTRACT ID: 181 C54 - Survival After Resection of Poorly Differentiated Gastroenteropancreatic Neuroendocrine Neoplasm: Association of Nodal Involvement and Survival Published in 2020 Listed under Clinical-Surgical-Applied_Pathology Download L. Thornblade, L. Melstrom, S. Warner, P. Ituarte, S. Chang, D. Li, Y. Fong1 G. Singh ABSTRACT ID: 190 C55 - The Proliferative Indices of the Primary Ileal Well-Differentiated Neuroendocrine Tumors, Corresponding Lymph Nodes/ Mesenteric Deposits, and Distant Metastatic Sites Show Poor Correlation Published in 2020 Listed under Clinical-Surgical-Applied_Pathology Download J. Lee, I. González, N. Trikalinos, D. Chatterjee ABSTRACT ID: 204 C6 - Efficacy of Checkpoint Inhibitors in Neuroendocrine Neoplasms: The Mayo Clinic Experience Published in 2020 Listed under Clinical-Chemotherapy-SSA-Biologics Download J. Gile, A. Liu, P. McGarrah, R. Eiring, J. Starr, M. Sonbol, T. Hobday, T. Halfdanarson ABSTRACT ID: 125 C7 - Safety in Patients With Neuroendocrine Tumors Receiving Telotristat Ethyl (TE) With Peptide Receptor Radionuclide Therapy (PRRT) Published in 2020 Listed under Clinical-Chemotherapy-SSA-Biologics Download A. Chauhan, P. Binder, E. Tesfaye, K. Seth, P. Lapuerta ABSTRACT ID: 130 C8 - Lanreotide Autogel (LAN) 120 mg Every 14 Days in Progressive Pancreatic Neuroendocrine Tumors (panNETs): CLARINET FORTE Study Published in 2020 Listed under Clinical-Chemotherapy-SSA-Biologics Download M. Pavel, J. Ćwikła, C. Lombard-Bohas, I. Borbath, T. Shah, U.-F. Pape, X.-M. Truong Thanh, A. Houchard, P. Ruszniewski ABSTRACT ID: 135 C9 - Lanreotide Autogel (LAN) 120 mg Every 14 Days in Progressive Midgut Neuroendocrine Tumors (NETs): CLARINET FORTE Study Published in 2020 Listed under Clinical-Chemotherapy-SSA-Biologics Download M. Pavel, J. Ćwikła, C. Lombard-Bohas, I. Borbath, T. Shah, U.-F. Pape, X.-M. Truong Thanh, A. Houchard, P. Ruszniewski ABSTRACT ID: 136 O1 - Neuroendocrine Wellness Clinic – Holistic Care Delivery to Patients With Metastatic Neuroendocrine Tumors Published in 2020 Listed under Other Download A. Laffan ABSTRACT ID: 79 O10 - The Use of Octreotide LAR in Routine Canadian Practice: Dosing Considerations and Persistence Rates Published in 2020 Listed under Other Download S. Singh, W. Cheung, H. Gourdeau ABSTRACT ID: 178 O11 - Neuroendocrine Carcinoma of the Rectum & Anus: Patient Characteristics and Treatment Modalities Published in 2020 Listed under Other Download B. Ueberroth, A. Liu, T. Halfdanarson, M. Sonbol ABSTRACT ID: 191 O2 - Development and Validation of the Disease-Specific QOL-CD Quality of Life Questionnaire for Patients with Cushing’s Disease Published in 2020 Listed under Other Download M. Cusimano, T. Huang, A. Marchie, H. Smyth, K. Kovacs ABSTRACT ID: 108 O3 - Survey of Challenges in Access to Diagnostics and Treatment for Neuroendocrine Tumor (NET) Patients (SCAN) – USA and Canada vs Global Diagnosis of NETs Published in 2020 Listed under Other Download E. Gellerman, J. Herman, M. McDonnell, D. Van Genechten, M. Pavel, D. O'Toole, H. Singh, J. Chen, J. Howe, S. Singh, C. Bouvier, C. Rodien-Louw, S. Leyden, S. Dureja, T. Kolarova ABSTRACT ID: 126 O4 - Identifying Care Processes Promoting Person-Centred Care for Patients Diagnosed With Neuroendocrine Tumours (NETs) Published in 2020 Listed under Other Download J. Hallet, V. Zuk, L. Moody, D. Chan, M. Michael, T. Halfdanarson, R. Pommier, S. Myrehaug, R. Goodwin, C. Law, J. Herman, S. Sohail, F. Wright, L. Gotlib Conn ABSTRACT ID: 129 O5 - Supporting Accurate Patient Information for An Uncommon Malignancy: Evaluation of the Quality of Information on Neuroendocrine Tumors (NETs) on the Internet Published in 2020 Listed under Other Download S. Sohail, V. Zuk, T. Halfdanarson, D. Chan, S. Pattison, R. Vasdev, C. Law ABSTRACT ID: 131 O6 - Diagnostic Effectiveness of Chromogranin A and Multigene Liquid Biopsy (NETest) in Neuroendocrine Neoplasia: An assessment of Monoanalyte and Multianalyte Biomarker Efficacy Published in 2020 Listed under Other Download A. Malczewska, K. Oberg, B. Kos-Kudla ABSTRACT ID: 153 O7 - Stereotactic Ablative Radiotherapy for the Management of Neuroendocrine Liver Metastases Published in 2020 Listed under Other Download J. Hudson, H. Chung, W. Chu, A. Taggar, L. Davis, J. Hallet, C. Law, S. Singh, S. Myrehaug ABSTRACT ID: 166 O8 - Role of Chromogranin A-derived Fragments as Biomarkers for Pancreatic Neuroendocrine Tumors (PanNET) Published in 2020 Listed under Other Download V. Andreasi, S. Partelli, M. Manzoni, B. Colombo, F. Muffatti, A. Corti, M. Falconi ABSTRACT ID: 168 O9 - Patient Experience with Somatostatin Analog Treatments for Neuroendocrine Tumors: Insight from Qualitative Interviews Published in 2020 Listed under Other Download C. Seo, E. Horodniceanu, R. Shah, G. Goldstein, D. Ray, B. Bennett, A. Phan, K. McCarrier ABSTRACT ID: 171 P1 - Cross-Sectional Study Assessing the Feasibility of Using NET VITALS Communication Tool Among Patients With Neuroendocrine Tumors Published in 2020 Listed under Population Science Download D. Li, G. Imbesi, L. Yen, H. Kim, C.L. Sun, R. Allen, M. Sedrak, G. Singh ABSTRACT ID: 37 P10 - A Neuroendocrine Tumor (NET) Patient Survey of Experiences with Telemedicine during the COVID-19 Pandemic Published in 2020 Listed under Population Science Download Y. Mattison ABSTRACT ID: 183 P11 - Intensive Personalized Program for Living with NENs as a Chronic Disease Published in 2020 Listed under Population Science Download M. Rosenberg, S. Glasberg, T. Whyand ABSTRACT ID: 186 P2 - Trends in the Incidence and Survival Outcomes in Patients With Lung Neuroendocrine Neoplasms in the United States Published in 2020 Listed under Population Science Download S. Shah, R. Gosain, A. Groman, R. Gosain, A. Dasari, T. Halfdanarson, S. Mukherjee ABSTRACT ID: 73 P3 - Upfront Small Bowel Resection for Small Bowel Neuroendocrine Tumors With Synchronous Metastases: A Propensity Matched Comparative Population-Based Analysis Published in 2020 Listed under Population Science Download S. Bennett, N. Coburn, C. Law, V. Zuk, A. Mahar, L. Davis, S. Singh, S. Myrehaug, V. Gupta, J. Levy, J. Hallet ABSTRACT ID: 76 P4 - Mapping the Patient Journey to Neuroendocrine Tumor (NET) Diagnosis Using Real-World Data (RWD) Published in 2020 Listed under Population Science Download N. Zimmerman, D. Ray, N. Princic, M. Moynihan, C. Clarke, A. Phan ABSTRACT ID: 98 P5 - Costs Associated with Misdiagnoses of Neuroendocrine Tumors (NET) Published in 2020 Listed under Population Science Download A. Phan, D. Ray, N. Princic, M. Moynihan, C. Clarke ABSTRACT ID: 99 P6 - Real World Analysis of Misdiagnosis Among Patients with Neuroendocrine Tumors (NET) Published in 2020 Listed under Population Science Download C. Clarke, D. Ray, N. Princic, M. Moynihan, A. Phan ABSTRACT ID: 100 P7 - Retrospective Analysis of DIPNECH and Carcinoid Tumorlets Progressing to Invasive Pulmonary Carcinoid Tumors Published in 2020 Listed under Population Science Download T.Y. Sun, A. Codima, G. Hwang, K. Hornbacker, D. Pancirer, N. Lui, R. Raj, P. Kunz, S. Padda ABSTRACT ID: 140 P8 - Breakthrough Symptoms Remain an Unmet Need in Symptomatic Patients with Neuroendocrine Tumors [175] Published in 2020 Listed under Population Science Download E. Liu, K. Hoffman, G. Murfin ABSTRACT ID: 175 P9 - Risk of Cancer-Specific Death for Patients Diagnosed With Neuroendocrine Tumors (NETs): A Population-Based Analysis Published in 2020 Listed under Population Science Download J. Hallet, V. Zuk, S. Singh, C. Law, A. Mahar, S. Myrehaug, H. Zhao, A. Assal, N. Coburn ABSTRACT ID: 180 T1 - Circulating Tumor DNA (Ct DNA) as a Biomarker in High- Grade Gastroenteropancreatic Neuroendocrine Tumor Published in 2020 Listed under Trials In Progress Download S. Mukherjee, M. Choi, R. Ramirez, K. Attwood, R. Iyer ABSTRACT ID: 116 T2 - A Phase I Trial of Triapine and Lutetium Lu 177 Dotatate in Combination for Well-Differentiated Somatostatin Receptor-Positive Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) Published in 2020 Listed under Trials In Progress Download A. Chauhan, C. Kunos, R. El Khouli, J. Kolesar, B.M. Evers, M. Kidd, E. Kohn, L. Anthony ABSTRACT ID: 155 T3 - Cabozantinib in High Grade Neuroendocrine Neoplasm Published in 2020 Listed under Trials In Progress Download N. Trikalinos, D. Chatterjee, C. Hammill, E. Lu, K. Pedersen, H. Park, R. Suresh, A. Wang-Gillam, K.-H. Lim, N. Bagegni, R.C. Fields, B. Tan, P. Grierson, O. Aranha, K. Winter, M. Amin ABSTRACT ID: 161 T4 - Randomized, parallel arm, Phase II Study of Telotristat in combination with Lutetium Lu 177 Dotatate (Lutathera) in Well-Differentiated Neuroendocrine Tumors (NETs) Published in 2020 Listed under Trials In Progress Download A. Chauhan, S. Arnold, R. El Khouli, H. Weiss, L. Faul, L. Anthony ABSTRACT ID: 188 The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and or Unresectable Pheochromocytoma and Paraganglioma (1) (4) Published in 2020 Download Select the number of documents per page 5 10 15 20 25 30 50 100
